Aprameya Engineering (NSE:APRAMEYA) Marketable Securities: ₹71.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:APRAMEYA Aprameya Engineering Ltd NSE:APRAMEYA
41 GF Score
Price ₹148.15
! 6 Warning Signs
View Full Analysis

What is Aprameya Engineering Marketable Securities?

Aprameya Engineering NSE:APRAMEYA -3.67% 41 Marketable Securities is ₹71.2 Mil as of Mar. 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Aprameya Engineering's Marketable Securities for the quarter that ended in Mar. 2026 was ₹71.2 Mil.

Aprameya Engineering's annual Marketable Securities stayed the same from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.0 Mil) but then increased from Mar. 2025 (₹0.0 Mil) to Mar. 2026 (₹71.2 Mil).

Aprameya Engineering  (NSE:APRAMEYA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Aprameya Engineering Marketable Securities Related Terms

Aprameya Engineering Marketable Securities Historical Data

* Premium members only.

The historical data trend for Aprameya Engineering's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprameya Engineering Marketable Securities Chart

Aprameya Engineering Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 71.18

Aprameya Engineering Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 48.14 71.18
NSE:APRAMEYA
41GF Score
Aprameya Engineering Ltd NSE:APRAMEYA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aprameya Engineering Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹71.2 Mil mean?
Aprameya Engineering (NSE:APRAMEYA) has a Marketable Securities of ₹71.2 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aprameya Engineering and its competitors.
Is Aprameya Engineering's Marketable Securities too high?
Aprameya Engineering's current Marketable Securities is ₹71.2 Mil. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Marketable Securities compare to ISRG and BDX?
Aprameya Engineering's Marketable Securities of ₹71.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aprameya Engineering and its competitors. Aprameya Engineering's current Marketable Securities is ₹71.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Marketable Securities of ₹71.2 Mil. The current Marketable Securities is ₹71.2 Mil. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Marketable Securities is ₹71.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprameya Engineering Business Description

Address 908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score

Get the complete analysis for NSE:APRAMEYA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹148.15
Price